Benyao Y. Lin
Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Combined Pathological Response and PEPI Score Improves Long-term Prognostic Stratification in HR-positive Breast Cancer Following Neoadjuvant Endocrine Therapy.
Journal: In vivo (Athens, Greece)
Published: April 08, 2026
Comparison of Survival After Breast-Conserving Therapy vs Mastectomy Among Patients With or Without the BRCA1/2 Variant in a Large Series of Unselected Chinese Patients With Breast Cancer.
Journal: JAMA network open
Published: April 23, 2021
Impact of the addition of carboplatin to anthracycline-taxane-based neoadjuvant chemotherapy on survival in BRCA1/2-mutated triple-negative breast cancer.
Journal: International journal of cancer
Published: April 19, 2020
Clinical phenotypes combined with saturation genome editing identifying the pathogenicity of BRCA1 variants of uncertain significance in breast cancer.
Journal: Familial cancer
Published: December 26, 2019
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers in a large cohort of unselected Chinese breast cancer patients.
Journal: International journal of cancer
Published: October 14, 2019
Spectrum and clinical relevance of PALB2 germline mutations in 7657 Chinese BRCA1/2-negative breast cancer patients.
Journal: Breast cancer research and treatment
Published: September 10, 2019
BRCA1 c.5470_5477del, a founder mutation in Chinese Han breast cancer patients.
Journal: International journal of cancer
Published: July 28, 2019
Co-mutation of TP53 and PIK3CA in residual disease after neoadjuvant chemotherapy is associated with poor survival in breast cancer.
Journal: Journal of cancer research and clinical oncology
Published: January 14, 2019
Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer.
Journal: International journal of cancer
Published: November 30, 2018
Prevalence and characterization of ATM germline mutations in Chinese BRCA1/2-negative breast cancer patients.
Journal: Breast cancer research and treatment
Published: November 09, 2018
Last Updated: 09/26/2026